Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Celgene Corporation (CELG)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Celgene's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Celgene historical data, for real-time data please try another search
108.24 0.00    0.00%
20/11 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 109.00 / 109.40
  • Day's Range: 107.27 - 108.59
Celgene 108.24 0.00 0.00%

CELG Income Statement

 
Featured here, the Income Statement (earnings report) for Celgene Corporation, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Income Statement
Period Ending: 2019
30/09
2019
30/06
2019
31/03
2018
31/12
Total Revenue 4520 4400 4025 4037
Revenue 4520 4400 4025 4037
Other Revenue, Total - - - -
Cost of Revenue, Total 167 151 140 169
Gross Profit 4353 4249 3885 3868
Total Operating Expenses 2256 2289 2315 2230
Selling/General/Admin. Expenses, Total 781 793 773 850
Research & Development 1167 1100 1216 1138
Depreciation / Amortization 109 109 109 127
Interest Expense (Income) - Net Operating - - - -
Unusual Expense (Income) 32 136 77 -54
Other Operating Expenses, Total - - - -
Operating Income 2264 2111 1710 1807
Interest Income (Expense), Net Non-Operating -364 -305 121 -691
Gain (Loss) on Sale of Assets - - - -
Other, Net 17 15 -17 1
Net Income Before Taxes 1917 1821 1814 1117
Provision for Income Taxes 226 250 269 123
Net Income After Taxes 1691 1571 1545 994
Minority Interest - - - -
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 1691 1571 1545 994
Total Extraordinary Items - - - 79
Net Income 1691 1571 1545 1073
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items 1691 1571 1545 994
Dilution Adjustment - - - -
Diluted Net Income 1691 1571 1545 1073
Diluted Weighted Average Shares 729.5 726.7 720.5 714
Diluted EPS Excluding Extraordinary Items 2.32 2.16 2.14 1.39
DPS - Common Stock Primary Issue - - - -
Diluted Normalized EPS 2.36 2.32 2.24 1.32
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CELG Comments

Write your thoughts about Celgene Corporation
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Karl Johannessen
Karl Johannessen Dec 12, 2019 3:42AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Oh Yeah, baby!
Bender B Rodriguez
Bender B Rodriguez Jun 24, 2019 11:27AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Anyone know what they plan to do with the capital from divestitures ahead of merger?  Special dividend or spin off would be nice :D
Moshe Genossar
Moshe Genossar Jun 24, 2019 11:27AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
True
Karl Johannessen
Karl Johannessen Apr 22, 2019 4:15AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What happens to CELG call options (CELG JAN 15, 2021 100.00) when the buy out occurs?. . . Thanks in advance
Bender B Rodriguez
Bender B Rodriguez Apr 22, 2019 4:15AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.investopedia.com/ask/answers/06/optionsbuyout.asp
Bender B Rodriguez
Bender B Rodriguez Apr 22, 2019 4:15AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I just realized that link doesn't answer much of anything. Very good question though
Salma Ghaith
Salma Mar 29, 2019 5:17PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
94.34 today
Jeff Bailey
JeffB Mar 29, 2019 3:43PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
94.38 +7.94% ... awesome!
edgar blumenthal
edgar blumenthal Mar 29, 2019 3:43PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Shows essence of Value Invest Trading indeed!
Evrytingisawsum !
Evrytingisawsum ! Jan 22, 2019 9:55AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what an opportunity to buy....amazing
Evrytingisawsum !
Evrytingisawsum ! Jan 18, 2019 3:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sure is behaving oddly
John Wilson
John Wilson Jan 04, 2019 7:55PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Is it just me but ever since the hemp business is starting to get legal medical companies are starting to panic.
Bender B Rodriguez
Bender B Rodriguez Jan 04, 2019 7:55PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Certainly some will be worried. Not sure the immunology biotechs have much to worry about. Opioids will but right now it looks like they have been troubles ahead!
Evrytingisawsum !
Evrytingisawsum ! Jan 04, 2019 11:07AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this will rip
Evrytingisawsum !
Evrytingisawsum ! Jan 04, 2019 11:07AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
rip indeed
Eli Schachar
Eli Schachar Jan 03, 2019 1:50PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what is the target price
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email